Regarding less common EGFR-mutations, the relative scarcity of clinical cases analyzed has precluded for quite some time the possibility of drawing firm conclusions on their response to different EGFR-TKIs in NSCLC patients and their possible role in intrinsic resistance. Here, EGFR is linked to non-small cell lung carcinoma.